Default: Schizophrenia Research

ISSN: 0920-9964

Journal Home

Journal Guideline

Schizophrenia Research Q1 Unclaimed

Elsevier B.V. Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Schizophrenia Research is a journal indexed in SJR in Psychiatry and Mental Health and Biological Psychiatry with an H index of 199. It has a price of 2395 €. It has an SJR impact factor of 1,374 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,374.

Schizophrenia Research focuses its scope in these topics and keywords: schizophrenia, symptoms, patients, psychosis, study, exposure, risk, cognitive, matter, effects, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Schizophrenia Research

1,374

SJR Impact factor

199

H Index

372

Total Docs (Last Year)

1305

Total Docs (3 years)

17953

Total Refs

4056

Total Cites (3 years)

984

Citable Docs (3 years)

2.55

Cites/Doc (2 years)

48.26

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


schizophrenia, symptoms, patients, psychosis, study, exposure, risk, cognitive, matter, effects, episode, negative, life, year, longitudinal, assessment, prodrome, napls, magnetic, gene, firstepisode, evidence, overview,



Best articles by citations

Awareness of psychopathology, extrapyramidal symptoms and subjective depression in out-patients attending for antipsychotic depot injection

View more

National needs assessment of long-stay hospitalized schizophrenic patients in Israel

View more

Topographic differences of the postimperative negative variation between schizophrenics and controls

View more

Cerebral lateralization of global-local processing in people with schizotypy

View more

Use of psychiatric services by patients with schizophrenia and related psychoses

View more

Schizophrenia research activities in non-english speaking countries (13 EEC and 4 asian countries): A medline survey

View more

Schizophrenic patients do not spend enough time in one specific brain state: Evidence from brain-electric field analysis

View more

State-trait aspects of polysomnographic abnormalities in schizophrenia

View more

Schizophrenic patients exhibit increased sensorimotor cortex activation with equal performance level

View more

Schizophrenics show reduced stroop interference if long-latency responses are excluded

View more

Electrophysiological evidence for reduced latent inhibition in schizophrenic patients

View more

Spectral analysis of the EEG in schizophrenia

View more
SHOW MORE ARTICLES

Serial analysis of gene expression of brain tissue from individuals with schizophrenia and bipolar disorder

View more

Event-related potentials and selective attention in healthy volunteers and schizophrenic patients with negative syndrome

View more

Immune-biochemical interactions in schizophrenia

View more

Localization of hypo- and hyperactivity in neuroleptic-naive, first-break, acute, productive schizophrenia using low resolution electromagnetic tomography (loreta) registered to the talairach human brain atlas

View more

The effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenic patients

View more

Polysomnographic abnormalities in schizophrenia: A replication

View more

Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics

View more

Eye tracking dysfunction (ETD) As a measurable indicator for the vulnerability to schizophrenia

View more

Cortico-cortical connectivity measured with EEG coherence in early versus late maturers: Developmental implications for schizophrenia

View more

The description of characteristics of HIV seroconversion in schizophrenic patients and of a prevention program

View more

Time of day of testing and neuropsychological performance of schizophrenic patients and healthy controls

View more

Dimensions of psychosis in affected sibling pairs

View more

FAQS